CRISPR human editing

Christopher Thomas Scott Stanford Center for Biomedical Ethics Director, Program on Stem Cells in Society   A decade ago I wrote an article in the journal Nature Biotechnology about the rise of a new gene editing technology called zinc finger nucleases (ZNF). It was one of those “drumbeat” discoveries: at the time, my sense was it would revolutionize how we deliver genes to cells and tissues, and profoundly change the way we think about gene therapy. I was partially right. Although ZNFs are now …Read More